Siltronic cuts 2025 guidance on forex headwinds despite Q2 beat

Siltronic AG reported better-than-expected Q2 results, with sales of €329.1 million and EBITDA of €86.4 million, largely attributed to a delayed activation of depreciation expenses. Despite this, the company cut its full-year 2025 sales guidance to mid-single-digit below the prior year, primarily due to revised foreign exchange assumptions, while maintaining its EBITDA margin forecast. Wafer demand remains subdued with elevated customer inventories, leading to an expected Q3 revenue dip before a Q4 recovery, and net debt increased to €902.8 million.

Analysis

Siltronic AG presented a mixed financial picture, reporting second-quarter results that beat consensus while simultaneously lowering its full-year 2025 sales guidance. Q2 sales of €329.1 million were down 6.3% year-over-year but came in 2% above expectations. The more significant development was the Q2 EBITDA of €86.4 million, which exceeded consensus by 25%. However, this outperformance was primarily attributed to a non-operational timing benefit from the delayed activation of depreciation and amortization expenses, rather than underlying business strength. The company's full-year sales guidance was revised downward to a mid-single-digit decline from the previous year, citing unfavorable foreign exchange assumptions with the EUR/USD rate now projected at 1.15. Despite the top-line reduction, the EBITDA margin forecast was maintained at 21-25%, supported by a lower depreciation outlook. This guidance reflects a challenging market environment characterized by subdued wafer demand, elevated customer inventories, and volume postponements, leading the company to project lower sequential revenues in Q3 before a potential recovery in Q4. The balance sheet shows signs of stress, with negative cash flow of -€83.4 million contributing to an increase in net debt to €902.8 million, or approximately 2.6 times EBITDA.

Key Decisions for Investors

• Investors should look past the headline Q2 EBITDA beat, as it was driven by a non-operational timing shift in depreciation rather than fundamental strength.
• The reduced sales guidance due to FX and weak demand presents a clear headwind, but the maintained EBITDA margin forecast suggests potential resilience in profitability that warrants monitoring.
• Pay close attention to the deteriorating balance sheet, as rising net debt to 2.6x EBITDA and negative cash flow are significant concerns, making the projected Q4 demand recovery a critical factor.
• Given the explicit warning of a weaker Q3 followed by a stronger Q4, anticipate near-term stock price pressure and look for confirmation of the fourth-quarter recovery as a key catalyst.